Bovine Viral Diarrhea Virus Antibodies Research Articles

First report of bovine viral diarrhea virus and Mycobacterium avium subspecies paratuberculosis infection in Tibetan sheep (Ovis aries) in Tibetan Plateau, China.

Bovine viral diarrhea virus (BVDV) and Mycobacterium avium subspecies paratuberculosis (MAP) are important pathogens, which cause serious disease in animals. However, information about BVDV and MAP infection in Tibetan sheep in China is limited. Two thousand one hundred and eighty-seven blood samples were collected from Tibetan sheep between April 2013 and March 2014 from the Tibetan Plateau and tested for BVDV and MAP antibodies using commercial ELISA kits. The overall seroprevalence of BVDV and MAP in Tibetan sheep was 36.7 and 11.29%, respectively. Furthermore, risk factor analysis indicated that the age of sheep was statistically significant associated with BVDV infection and the region was considered as the risk factor of MAP infection in sheep (P < 0.05), gender and season were not considered as risk factors. This is the first report of seroprevalence and risk factors associated with BVDV and MAP infection in Tibetan Sheep in China, which will provide baseline information for controlling BVDV and MAP infection in ruminants in the Tibetan Plateau, western China.

Epidemiological surveillance of bovine viral diarrhea and rift valley fever infections in camel.

Aim:This study was designed to investigate the current epidemiological situation of bovine viral diarrhea virus (BVDV) and rift valley fever virus (RVFV) infection of camels originating from Sudan “smuggler” and Egypt as part of our future plan for a national surveillance program in Egyptian provinces, which will aid in establishment of control strategy for animal diseases.Materials and Methods:This investigation was accomplished using serological diagnostic and molecular biology techniques. A total number of 200 blood samples were collected from camel (120 originated from Sudan “smuggler” and 80 from local breed) and were subjected for testing both BVDV and RVFV occurrence with different age and sex.Results:Sixty-six of the 200 camels (33%) were positive for BVDV antibodies, and 44 (22%) for BVDV antigen (Ag), and 27 of the 200 camels (13.5%) were positive for RVFV immunoglobulin G (IgG) antibodies. On the other hand, the seroprevalence of BVDV for antibodies (47.5%), Ag (31.6%), and RVFV IgG antibodies (16.6%) was higher in camel originated from Sudan “smuggler” than of local breed which was 11.2% for BVDV antibodies and 7.5% for BVDV Ag, while it was 8.7% for RVFV IgG antibodies. The incidence of BVDV antibodies, Ag, and RVFV IgG antibodies was the highest in male, up to 9 years of age. The frequency of positive cases was significantly different according to the origin of samples and sex and age of camel for BVDV and RVFV. In addition, seven serologically positive samples for BVDV and five serologically positive samples for RVFV were submitted as a buffy coat for molecular detection by one-step – reverse transcription polymerase chain reaction (RT-PCR). The results demonstrated that three samples were positive for BVDV of camel originated from Sudan (smuggler), while no RVFV Ag was detected in all five samples. Sequencing and phylogenetic analysis of the amplicons obtained from positive RT-PCR samples (three samples) indicated 100% nucleotide homology with Sudan strain 2015 except only one (missense point mutation) by substitution of A to T at position 345 that changed the coded amino acids from T (Threonine) to S (Serine) at residue 115.Conclusion:Camels act as risk animals for the introduction of many infectious diseases from Sudan to Egypt, especially transboundary animal diseases, so strict quarantine measures should be taken during importation of live animals from Sudan to prevent the spread of such diseases.

Strategies for screening young stock for antibodies \u2013 optimising numbers to test, cut-points, & predictive values for bovine viral diarrhoea virus

The antibody seroprevalence of young stock can be a useful indicator of recent or current infection in a herd. We examine the factors that contribute to the assessment of herd exposure to disease, via spot testing for antibody, using bovine viral diarrhoea virus (BVDv) as an example. A statistical distribution of seroprevalences for BVDv in beef herds identified three groups of herds: low, intermediate and high within-herd BVDv antibody seroprevalence. We tested two assumptions –the intermediate seroprevalence group of herds is assumed to be negative for BVDv at the herd level and alternatively if this group is assumed to be positive. We found that: The herd-level sensitivity and specificity are sensitive to the assumption regarding the herds with intermediate seroprevalence. If an appropriate cut-point is chosen, reducing the sample size from ten to five does not produce a large drop in herd-level test performance. Increasing the cut-point may be valuable at the outset of an eradication programme. Increasing the sample size and decreasing the cut-point is advantageous towards the end of an eradication programme, to minimise the risk of positive herds being misclassified. The framework presented here illustrates how seroprevalence screening may be understood and assessed.

Effects of a Saccharomyces cerevisiae fermentation product in receiving diets of newly weaned beef steers. I. Growth performance and antioxidant defense1.

To evaluate the effects of a Saccharomyces cerevisiae fermentation product (SCFP; Original XPC, Diamond V, Cedar Rapids, IA) on growth performance and antioxidant defense of newly weaned beef cattle, 180 single-source steers (278 ± 21 kg; SD) were used in a 56-d receiving study. Seven days after arrival, steers were blocked by body weight (BW) to pens of 6 and randomly assigned to treatments: SCFP at 0 (CON), 14 (SCFP14), or 28 (SCFP28) g·steer-1·d-1. Pen was the experimental unit (n = 10 per treatment). On day 0, steers were boostered against Bovine Viral Diarrhea Virus (BVDV) Type 1 and 2 (Vista Once, Merck, Madison, NJ). Weights were collected on days 1, 0, 14, 27, 42, 55, and 56. One steer per pen was bled on days 0, 14, 27, 42, and 56 for analysis of BVDV antibody titers; blood from days 0, 27, and 56 was analyzed for red blood cell lysate superoxide dismutase (SOD) activity and glutathione (total = tGSH, oxidized = GSSG, and reduced = GSH) concentrations, plasma malondialdehyde (MDA) concentrations, and serum lysozyme activity. Performance and blood data were analyzed as a randomized complete block design using Proc Mixed of SAS with fixed effects of treatment and block and random effect of pen. Linear and quadratic contrast statements were used. Antibody titers were log transformed and analyzed as repeated measures. There were no treatment by day interactions (P ≥ 0.16), and no linear or quadratic effects of SCFP on feedlot performance, antibody titers, or lysozyme activity (P > 0.10). Day 27 MDA concentrations tended to linearly increase (P = 0.09). A quadratic effect of SCFP on day 56 SOD activity (P = 0.004) was driven by lesser activity for SCFP14-fed steers. On day 27, a tendency for a quadratic effect of SCFP (P = 0.09) on GSH was driven by greater concentrations for SCFP14-fed steers resulting in a lesser GSSG:GSH ratio (P = 0.05). Greater GSH for SCFP14-fed steers caused a tendency for a quadratic effect on day 56 (P = 0.07); however, this did not result in an effect of SCFP on the GSSG:GSH ratio (P ≥ 0.25). A tendency for a linear effect of SCFP on tGSH was noted on day 56 (P = 0.09). Morbidity data were analyzed using Proc Glimmix of SAS. There was a quadratic effect of SCFP on percentage of respiratory treatments prior to day 14 (P = 0.04). These results could indicate lesser levels of oxidative stress for steers receiving SCFP at 14 vs. 0 or 28 g/d. Under the conditions of this study, no performance benefit of SCFP was noted.

PREVALENCE OF ANTIBODIES AND RISK FACTORS TO BOVINE VIRAL DIARRHEA IN NON-VACCINATED DAIRY CATTLE FROM SOUTHERN ECUADOR

&lt;div class="page" title="Page 1"&gt;&lt;div class="layoutArea"&gt;&lt;div class="column"&gt;&lt;p&gt;&lt;span&gt;The aim of this work was to determine the prevalence of antibodies and risk factors of bovine viral diarrhoea virus (BVDV) in non-vaccinated dairy cattle at the South of Ecuador. A cross-sectional study was carried out to identify risk factors for BVDV infection in 394 randomly selected dairy cows from 75 farms, which were tested for antibodies in milk samples using a commercial Kit ELISA (IDEXX). Epidemiological survey was conducted to determine the risk factors and signs associated with BVDV. Results of this test revealed that the BVDV herd prevalence was 63.5% and the BVDV individual prevalence was 27%. The utilization of artificial insemination (AI) was significantly associated with BVDV status (P &amp;gt; 0.001) where the use of AI increased 2.35 the odds of BVDV positivity (95% CI: 1.46 &lt;/span&gt;&lt;span&gt;– &lt;/span&gt;&lt;span&gt;3.38). The cows with clinical signs (diarrhoea, abortions, and ocular and nasal discharge) were not predominantly positive to BVDV antibodies.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;

Natural transmission of bovine viral diarrhoea virus-1c from a persistently infected neonate lamb to naïve sheep and cattle

This study investigated the transmission of bovine viral diarrhoea virus (BVDV)-1c from a persistently infected (PI) neonate lamb to naïve sheep and cattle using three treatment groups: four naïve ewes...

Herd-level risk factors for bovine viral diarrhea infection in cattle of Tamil Nadu.

A cross-sectional study was carried out to identify risk factors for bovine viral diarrhea virus (BVDV) infection in 62 randomly selected dairy herds which were tested for BVD serum antibodies by using an indirect ELISA kit (IDEXX). Results from the chi-square test analysis were interpreted by analyzing by chi-square test. A sum of 500 sera samples were screened and 66 animals (13.20%) showed positive for BVDV antibody. Within herd, BVD seroprevalence was 12-65%. This study concluded that epidemiological risk factors like location, herd size, housing patterns like, tail to tail system, roofing pattern, distance between the manure pit and farm, and distance between farms were significantly associated with BVDV serological status (P < 0.05).

Description of risk factors associated with the detection of BVDV antibodies in Brazilian pig herds.

Bovine viral diarrhea virus (BVDV) infects ruminants as primary hosts. However, other animals like pigs are susceptible. This study was conducted to investigate seroprevalence and risk factors associated with the detection of BVDV antibodies in pig herds. A total of 1.705 serum samples of 33 finisher herds, from seven Brazilian states, were collected in slaughterhouses. The samples were tested by virus neutralization (VN) test. In total, 5.35% (91/1.705) were positive and 64% (21/33) of the herds had positive animals. A significant association with "trucks are not cleaned and disinfected" and "visitors do not respect 72-h interval between visits to farms" (P < 0.05) was found in association with detection of BVDV-2 antibodies. This study suggests that important biosecurity gaps are present in Brazilian pig farms, as the presence of BVDV antibodies in pigs suggests (direct or indirect) contact with population(s) of ruminant species. Closing biosecurity gaps prevents spread of BVDV and other pathogens such as foot-and-mouth disease virus (FMDV) between pig and ruminant farms. This data should be taken in account by CSF surveillance programs, once cross-reaction in serologic tests between classical swine fever virus (CSFV) and BVDV antibodies has been shown to occur.

Prevalence of Candidatus Mycoplasma haemolamae, bovine viral diarrhoea virus, and gastrointestinal parasitism in a sample of adult New Zealand alpaca (Vicugna pacos)

AIM: To determine the prevalence of infection with Candidatus Mycoplasma haemolamae (Mhl), antibodies to bovine viral diarrhoea virus (BVDV), and BVDV antigen, and the prevalence of animals with elevated faecal nematode egg counts (FEC) in a sample of adult New Zealand alpaca (Vicugna pacos).METHODS: Blood samples were obtained from 175 alpaca, collected from 15 farms around New Zealand, and from 31 samples sent to a diagnostic laboratory for routine haematology. Blood smears (n=170) were examined microscopically for the presence of haemoplasma, and DNA was extracted from whole blood (n=206) for real-time PCR testing for Mhl. Packed cell volume (PCV) was determined for 193 samples. Serum samples (n=195) were tested for BVDV antibody using ELISA, and for BVDV antigen using a real-time PCR assay. Faecal samples were collected from 143 animals; FEC were measured, and samples pooled for larval culture.RESULTS: No haemoplasma organisms were present on blood smear examination. Of the 206 blood samples, two (from the same farm) were positive for Mhl by real-time PCR testing, giving a prevalence of infection with Mhl of 0.97%. Of the 195 serum samples tested, four (2.1%) were positive for antibodies to BVDV; animals with BVDV antibodies were from 3/15 (20%) farms, none of which farmed cattle. None of the serum samples were positive by PCR for BVDV antigen. The median FEC was 50 epg (min 0, max 4,700), with 55/143 (38.5%) samples having 0 epg, and 33/143 (23.1%) having ≥250 epg. Haemonchus spp. were the most common nematodes present in faecal larval cultures from the North Island. Log10 FEC was negatively associated with PCV (p=0.02), and was higher in males than females (p<0.001), and in animals that were positive compared with negative for Mhl (p=0.022).CONCLUSIONS AND CLINICAL RELEVANCE: The number of alpaca infected with Mhl was low, as was the seroprevalence of BVDV. Gastrointestinal parasitism was, however, a common finding in this sample of New Zealand alpaca.

First report on serological evidence of bovine viral diarrhea virus (BVDV) infection in farmed and free ranging mithuns (Bos frontalis).

Despite reports of BVDV infection in several domestic and wild ruminants, no information exists for mithun (Bos frontalis) species. Hence, this study was undertaken to determine prevalence of BVDV infection in mithuns, which contribute significantly to local economy in the North Eastern region of India. Blood and serum samples were collected between 2013 and 2016 from mithuns (n=466) belonging to the states of Nagaland, Mizoram, and Arunachal Pradesh. Serum samples were tested for BVDV antibodies by a commercial ELISA and leukocytes were tested for BVDV by real-time RT-PCR. The overall true seroprevalence rate was 13.1% (95% confidence interval, CI: 6.9-17.8%) with higher prevalence in mithuns reared under semi-intensive system (27.5%) than in free-ranging mithuns (7.6%). Among the three states, seroprevalence (16.2%) was highest in Nagaland, while prevalence rates varied markedly among geographical locations. Age-wise data showed highest seroprevalence rate in >6-year-old animals (20.6%) than 2-6years old (16.9%), 6months-2years old (8.5%), and <6-month-old animals (11.3%). The seroprevalence was higher in males (20.9%) than in females (12.1%). Among the four mithun strains, higher prevalence was evident in Manipur (30.3%) than Arunachal (21.3%), Nagaland (11.7%), and Mizoram strain (10.2%). However, no BVDV genomic RNA could be detected. The results provide first serological evidence of BVDV infection in mithun species and extend the knowledge on BVDV host range. The baseline data will help further investigations on epidemiology of BVD in mithun and its impact on mithun production.

Effect of injectable trace mineral administration on health, performance, and vaccine response of newly received feedlot cattle

ABSTRACT Previous research has established that trace minerals are necessary for optimal growth and immunity, yet challenges exist with intake of dietary trace minerals in cattle newly received at feedlots. A total of 128 crossbred beef bull (n = 40) and steer (n = 88) calves were used for this 42-d receiving study. Cattle were stratified by initial BW (275 ± 9.54 kg) and sex (steer or bull) and then assigned equivalently to treatment pens (n = 8 per treatment). Treatments were (1) negative control (CON) or (2) injectable trace mineral solution containing 60 mg of Zn/mL (as Zn disodium EDTA), 10 mg of Mn/mL (as Mn disodium EDTA), 5 mg of Se/mL (as sodium selenite), and 15 mg of Cu/mL (as Cu disodium EDTA) administered s.c. at 2.2 mL/100 kg of BW on d 0 (ITM). Health was monitored daily by trained personnel blinded to treatment pen assignment. Blood samples and BW were obtained on d 0, 14, 28, and 42 to determine bovine viral diarrhea virus (BVDV) type 1a antibody titer and gain performance. Standard processing procedures were applied on d 0, including administration of a respiratory vaccine containing modified-live BVDV antigens. No difference in overall ADG (P = 0.21) was detected between CON (1.36) and ITM (1.25 kg/d) steers. Overall DMI was not different (P = 0.83) between CON (6.98) and ITM (7.02 kg/d), but G:F tended (P = 0.08) to be less for ITM from d 28 to 42. The morbidity rate observed in this study was low (14% average), and there was no difference (P = 0.71) in morbidity between treatments, which averaged 15.6 and 12.5% for CON and ITM, respectively. There was a treatment × d interaction (P = 0.09) for BVDV-specific antibody titer. On d 14, ITM had a greater (P = 0.02) BVDV antibody titer than CON. These data suggest that ITM did not improve performance or morbidity when the incidence was low; however, the BVDV-specific antibody response to a respiratory vaccine was greater for ITM on d 14.

Antibodies to bovine viral diarrhoea virus (BVDV) in water buffalo (Bubalus bubalis) and cattle from the Northern Territory of Australia.

Farmed and feral water buffaloes (Bubalus bubalis) populations often coexist with cattle in the Northern Territory of Australia, but their level of exposure to bovine viral diarrhoea virus (BVDV) is unknown. Water buffalo (n = 245) and cattle (n = 184) serum samples were collected by the NT Government as part of an ongoing disease surveillance scheme at varying intervals between 1993 and 2001. All samples were frozen and stored at -80°C until testing. Water buffalo samples from farming properties were identified as 'farmed' animals and the remaining samples as 'feral' populations. Serum samples were analysed using commercially available ELISAs to test for the presence of BVDV antibodies. Testing of historical water buffalo sera for BVDV antibodies revealed a low level of exposure, with 4.5% (95% CI ± 2.6%) being sero-positive; cattle from the same geographical area and time period had higher levels of exposure at 74.5% (95% CI ± 6.3%). This survey showed that water buffalo are susceptible to infection with BVDV. No persistently infected water buffalo were identified in this study.

In this issue – November 2016

In this issue – November 2016

Comparative prevalence of Bovine Viral Diarrhea Virus antibodies among native and imported cattle in north of Sistan and Baluchistan- Iran

Comparative prevalence of Bovine Viral Diarrhea Virus antibodies among native and imported cattle in north of Sistan and Baluchistan- Iran

Dexamethasone treatment differentially alters viral shedding and the antibody and acute phase protein response after multivalent respiratory vaccination in beef steers.

Our objective was to examine immunosuppression induced by dexamethasone (DEX) administration in cattle on immunological responses to a multivalent respiratory vaccine containing replicating and nonreplicating agents. Steers ( = 32; 209 ± 8 kg) seronegative to infectious bovine rhinotracheitis virus (IBRV), bovine viral diarrhea virus (BVDV), bovine respiratory syncytial virus (BRSV), and parainfluenza-3 virus (PI3V) were stratified by BW and randomly assigned to 1 of 3 treatments: 1) acute immunosuppression (ACU; 0.5 mg/kg BW DEX intravenously at 1000 h only on d 0), 2) chronic immunosuppression (CHR; 0.5 mg/kg BW DEX intravenously at 1000 h on d -3 to 0), or 3) a control (CON; no DEX). On d -4, steers were fitted with intravenous catheters in the jugular vein and placed into individual stanchions. At 1200 h on d 0, steers were administered a respiratory vaccine containing modified-live virus (MLV) isolates of IBRV, BVDV, BRSV, and PI3V and a (MH) toxoid. On d 4, cattle were transported (177 km) and housed in an isolated outdoor pen. Serum was harvested on d 0, 7, 14, 21, 28, 35, 42, and 56 to determine IBRV-, BVDV-, BRSV-, and PI3V-specific antibody titers and MH whole cell and leukotoxin antibody concentrations. Sera from d -2, 0, 1, 3, 7, and 14 were used to quantify haptoglobin (Hp) concentration and ceruloplasmin (Cp) activity. Nasal swab specimens were collected on d 0, 3, and 14 to determine the presence of IBRV, BVDV, BRSV, and PI3V via PCR analysis. There was a treatment × day interaction ( < 0.01) such that CHR steers had a greater ( ≤ 0.07) BVDV antibody titer on d 14, 21, and 28. Moreover, IBRV-specific antibodies increased beginning on d 14 for CHR and on d 28 for ACU and remained greater through d 56 compared with CON ( ≤ 0.03). Conversely, serum MH whole cell antibody concentration was least ( ≤ 0.06) for CHR from d 7 to 28 and greatest for CON ( ≤ 0.04) on d 56. Treatment altered Hp such that CON exhibited a greater ( < 0.01) Hp concentration than CHR but was not different from ACU ( = 0.16). On d 3, Cp was greatest for CON, intermediate for ACU, and least for CHR (treatment × day; ≤ 0.01). The prevalence of IBRV and BVDV in nasal swabs on d 14 was 67 and 56%, respectively, for CHR; 10 and 10%, respectively, for CON; and 9 and 0%, respectively, for ACU ( ≤ 0.006). Results suggest that CHR allowed increased replication of MLV vaccine agents. Conversely, DEX-induced immunosuppression blunted the acute phase protein and antibody response against the nonreplicating MH toxoid.

Prevalence of antibodies to Bovine Viral Diarrhea Virus (BVDV) in blood and milk serum in dairy cattle in Kars district of Turkey

The purpose of this study was to detect of antibodies against Bovine Viral Diarrhea Virus (BVDV) in blood and milk serum samples. With this aim, a total of 192 blood and milk samples were collected from unvaccinated Holstein cows in Kars district of Turkey. Blood and milk serum samples were tested to determine the presence of antibodies against BVDV by commercial indirect enzyme-linked immunosorbent assay (ELISA). In this study, while 172 of blood serum (89.58%) were found to be positive for the presence of BVDV antibodies, 161 of milk serum samples (83.85%) were positive. In addition, 150 (78.12%) both blood and milk serum samples of same cattle were positive for BVDV antibodies. Only 22 (11.45%) blood serum of cattle was detected positive for BVDV, while only 11 (5.73%) milk serum was seropositive. Data obtained from the study showed the presence of BVDV infection in dairy herds in the Kars region and demonstrate that blood serum and milk serum samples might be consistent with one another in the determination of BVDV seroprevalence.

English

A seroprevalence study was carried out on serum samples obtained from blood of cattle slaughtered at Sokoto metropolitan abattoir, Sokoto, Nigeria. Systematic random sampling was used to select the animals. Serum samples of 372 cattle of different sexes and breeds were analyzed using ID Screen® BVD p80 Antibody Competition ELISA Test kit for the presence of bovine viral diarrhea antibodies. Two hundred and forty seven (247), representing 66.39% of the samples, were found positive for the antibodies against bovine viral diarrhea virus (BVDV). More female animals appeared to have BVDV antibodies than the males (p 0.05). The result of this research suggests that there is an existence of BVDV within the study area and that the spread of the BVDV antibodies seems to cut across sex and breed of cattle within the state. It is suggested that virological research on BVDV should be carried out in the state. Key words: Bovine viral diarrhea virus, antibodies, cattle, Sokoto metropolitan abattoir

Bovine Leukosis Virus and Antibodies against Bovine Herpesvirus Type-1 and Bovine Viral Diarrhea Virus and in Buffaloes of the State of Pará, Brazil

Background: Viral diseases affecting reproduction cause economic losses in cattle, as reproductive failure interrupts the production cycle, thus reducing herd productivity. Buffaloes are susceptible to most of the diseases that affect cattle. Some of the viral diseases of reproductive importance are infectious bovine rhinotracheitis (IBR), bovine viral diarrhea (BVD), and bovine leukosis (BL). The objective of this study was to determine the seroprevalence of IBR virus (bovine herpes virus-1, BoHV-1), BVD virus (BVDV), and BL virus (BLV) in female buffaloes living in wetland areas or plains in the state of Pará, as well as the seroprevalence of BoHV-1, BVDV, and BLV in females of different age groups.Materials, Methods &amp; Results: It were used 225 crossbred buffaloes from 4 buffalo exclusive farms. The buffaloes reared on farms A (n = 50) and B (n = 89) were kept in wetland areas on Marajó Island (n = 139), Pará. On farms C (n = 30) and D (n = 56) buffaloes were kept in plains (n = 86) in a northeastern mesoregion of Para. Animals were categorized into age groups: I: 0-3 years (n = 34), II: 3-6 years (n = 58), III: 7-9 years (n = 55), and IV: over 9 years (n = 78). Blood samples were collected and sera were sent for processing at the Bovine Virus Laboratory, Biological Institute of São Paulo, Brazil. The presence of IBRV and BVDV was determined by neutralization and BLV antibodies by immunodiffusion in agar gel. Statistical analysis was performed using the Ȥ2 test at a significance level of 5%. Among the seroprevalences of IBRV, BVDV and BLV antibodies, the difference in prevalence for BVD [P &lt; 0.01] was observed between wetland areas and plains of Para, varying from 12.4% to 96.0% and 0.0% to 13.3%, respectively. While levels of IBRV remained high on farms A (79.6%), B (86.5%), C (83.3%) and D (89.1%) [P = 0.60] and BLV was negative in all the animals. BVDV was similar for all the age groups [P = 0.60], while IBRV was more prevalent in animals over 6 years of age with group I: (76.5%), II (74.5%), III (92.3%) and IV (91.3%) [P = 0.01]. It was not possible verify the influence of age in prevalence for BL.Discussion: The prevalence obtained for the BoHV-1 on farms was high, with little variation between 79.6% and 89.1%. The high prevalence of BoHV-1 suggests the free circulation of the virus in the state of Para. Notably, the animals in this study had not been vaccinated, so the determined viral antibody titers were independent of vaccination. BVDV results showed high variation between 0.0% and 96.0%. The highest prevalence in wetland areas may be related to the breeding environment, because of a possible horizontal contamination. The lack of BLV antibodies prevalence can be attributed to the fact that all the evaluated animals were kept in an extensive breeding system where they had little direct contact. The prevalence of IBR was higher in the older animals. Variation in prevalence with age was not observed for BVD. It was concluded that the prevalence for IBR and BVD were high indicating that the etiological agents are circulating in Para, with IBR having a higher prevalence in older animals. Breeding buffalo in wetland areas may favor horizontal transmission of BVDV because facilitate contact of healthy animals with water contaminated by virus carriers animal secretion and the absence of seropositive animals at the BLV does not necessarily indicate that buffaloes are resistant to the virus.

Detection of bovine viral diarrhea virus antibodies in camels (&lt;i&gt;Camelus dromedarius&lt;/i&gt;) in Maiduguri, Nigeria

This study was carried out to determine the seroprevalence of bovine viral diarrhea virus (BVDV) antibodies in camels presented for slaughter at the Maiduguri abattoir using a BVDV specific indirect enzyme-linkedimmunosorbent assay (ELISA). Ninety (90) serum samples collected from adult male and female camels were tested for BVDV antibodies. From the samples tested, 28 (31.1%) were positive for BVDV. The sex distribution of the positive samples showed 7 (33.3%) males and 21 (30.4%) females were positive for BVDV antibodies. The results showed no statistically significant (p<0.05) difference in the sex prevalence of camels observed in the study. This finding demonstrates the presence of BVDV antibodies in camels in Maiduguri. Further studies will be required to elucidate the epidemiology of BVDV infection in camels and other livestock species in the study area.

Herd-level prevalence and risk factors for bovine viral diarrhea virus infection in cattle in the State of Paraíba, Northeastern Brazil

Serological surveys based on a planned sampling on bovine viral diarrhea virus (BVDV) infection in Brazilian cattle herds are scarce. A cross-sectional study was carried out to determine herd- and animal-level seroprevalences and to identify risk factors associated with herd-level seroprevalence for BVDV infection in the State of Paraíba, Northeastern Brazil, from September 2012 to January 2013. The state was divided into three sampling strata, and for each stratum, the prevalence of herds infected with BVDV and the prevalence of seropositive animals was estimated by a two-stage sampling survey. In total, 2443 animals were sampled from 478 herds. A virus-neutralization test was used for BVDV antibody detection. A herd was considered positive when at least one seropositive animal was detected. The herd- and animal-level prevalences in the State of Paraíba were 65.5% (95% confidence interval (CI) = 61.1-69.7%) and 39.1% (95% CI = 33.1-45.6%), respectively. The frequency of seropositive animals per herd ranged from 10 to 100% (median of 50%). The risk factors identified were as follows: more than six calves aged ≤12 months (odds ratio (OR) = 3.72; 95% CI = 2.08-6.66), animal purchasing (OR = 1.66; 95% CI = 1.08-2.55), pasture rental (OR = 2.15; 95% CI = 1.35-3.55), and presence of veterinary assistance (OR = 2.04; 95% CI = 1.10-3.79). Our findings suggest that the implementation of control and prevention measures among farmers, with the aim of preventing dissemination of the agent in the herds, is necessary. Special attention should be given to addressing the identified risk factors, such as sanitary control prior to animal purchasing and to discourage the pasture rental, as well as to encourage the vaccination in the herds.